scispace - formally typeset
A

Ana Griciuc

Researcher at Harvard University

Publications -  21
Citations -  1495

Ana Griciuc is an academic researcher from Harvard University. The author has contributed to research in topics: Microglia & Amyloid beta. The author has an hindex of 10, co-authored 20 publications receiving 1043 citations. Previous affiliations of Ana Griciuc include Protein Sciences & University of Tübingen.

Papers
More filters
Journal ArticleDOI

Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta

TL;DR: The minor allele of the CD33 SNP rs3865444, which confers protection against AD, was associated with reductions in both CD33 expression and insoluble amyloid beta 42 levels in AD brain and CD33 inhibition could represent a novel therapy for AD.
Journal ArticleDOI

TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease.

TL;DR: Crosstalk between CD33 and TREM2 includes regulation of the IL-1β/IL-1RN axis and a gene set in the "receptor activity chemokine" cluster that should facilitate AD therapeutics targeting these receptors.
Journal ArticleDOI

Inactivation of VCP/ter94 suppresses retinal pathology caused by misfolded rhodopsin in Drosophila.

TL;DR: These findings raise the possibility that excessive retrotranslocation and/or degradation of visual pigment is a primary cause of PN degeneration.
Journal ArticleDOI

The role of innate immune genes in Alzheimer's disease.

TL;DR: The role of the innate immune system and neuroinflammation in the pathogenesis of Alzheimer's disease, with an emphasis on microglial receptors CD33 and TREM2, was discussed in this article.